Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.8 USD | +0.53% | +17.65% | +2.80% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise | MT |
Business Summary
Number of employees: 8
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hyung-Heon Kim
CEO | Chief Executive Officer | 47 | 21-07-08 |
Director of Finance/CFO | 66 | 23-10-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
D. Strickland
BRD | Director/Board Member | 77 | 22-01-26 |
Andrew Koven
CHM | Chairman | 66 | 21-07-08 |
Mark Glickman
BRD | Director/Board Member | 58 | 23-05-10 |
Michael Salsbury
BRD | Director/Board Member | 74 | 19-12-30 |
Jason Groves
BRD | Director/Board Member | 52 | 19-12-30 |
James Tursi
BRD | Director/Board Member | 59 | Oct. 31 |
Hyung-Heon Kim
CEO | Chief Executive Officer | 47 | 21-07-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,906,002 | 1,880,689 ( 38.33 %) | 0 | 38.33 % |
Company contact information
NeuroBo Pharmaceuticals, Inc.
545 Concord Avenue Suite 210
02138, Cambridge
+
http://www.neurobopharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.80% | 18.64M | |
+9.15% | 106B | |
-1.08% | 104B | |
+7.05% | 23.25B | |
-11.55% | 22.5B | |
-7.05% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |
- Stock Market
- Equities
- NRBO Stock
- Company NeuroBo Pharmaceuticals, Inc.